Browse

You are looking at 651 - 700 of 871 items for

  • Refine by Access: All content x
Clear All
Restricted access

Section 9. Sexually Transmitted Diseases

Edited by Lea S. Eiland and Diane B. Ginsburg

Restricted access

1.1: General Pharmacokinetic Applications

Edited by John E. Murphy

Restricted access

1.1 Pediatric Patient Care Management

Jaime W. Riskin and Sandra Benavides

Restricted access

1.10: Phenobarbital

Edited by John E. Murphy

Restricted access

1.11: Phenytoin/Fosphenytoin

Edited by John E. Murphy

Restricted access

1.12: Valproic Acid

Edited by John E. Murphy

Restricted access

1.13: Vancomycin

Edited by John E. Murphy

Restricted access

1.14: Warfarin

Edited by John E. Murphy

Restricted access

1.2: Medication Dosing in Overweight and Obese Patients

Edited by John E. Murphy

Restricted access

1.3: Estimating Creatinine Clearance

Edited by John E. Murphy

Restricted access

1.4: Renal Drug Dosing

Edited by John E. Murphy

Restricted access

1.5: Aminoglycoside Antibiotics

Edited by John E. Murphy

Restricted access

1.6: Carbamazepine

Edited by John E. Murphy

Restricted access

1.7: Digoxin

Edited by John E. Murphy

Restricted access

1.8: Unfractionated Heparin and Low Molecular Weight Heparins

Edited by John E. Murphy

Restricted access

1.9: Lithium

Edited by John E. Murphy

Restricted access

10.1 Anemia—Level 1

Tracy M. Hagemann

Restricted access

10.1 Anemia—Level 1

Tracy M. Hagemann

Restricted access

10.2 Sickle Cell Disease—Level 2

Tracy M. Hagemann

Restricted access

10.2 Sickle Cell Disease—Level 2

Tracy M. Hagemann

Restricted access

10.3 Anticoagulation—Level 3

Brady S. Moffett

Restricted access

10.3 Anticoagulation—Level 3

Brady S. Moffett

Restricted access

2.1 Anaphylaxis—Level 1

Nicole M. Even and Hanna Phan

Restricted access

2.1 Anaphylaxis—Level 1

Nicole M. Even and Hanna Phan

Restricted access

2.1: General Pharmacokinetic Applications

Edited by John E. Murphy

Restricted access

2.10: Phenobarbital

Edited by John E. Murphy

Restricted access

2.11: Phenytoin/Fosphenytoin

Edited by John E. Murphy

Restricted access

2.12: Valproic Acid

Edited by John E. Murphy

Restricted access

2.13: Vancomycin

Edited by John E. Murphy

Restricted access

2.14: Warfarin

Edited by John E. Murphy

Restricted access

2.2: Medication Dosing in Overweight and Obese Patients

Edited by John E. Murphy

Restricted access

2.2 Nutrition—Level 2

Sandra Benavides

Restricted access

2.2 Nutrition—Level 2

Sandra Benavides

Restricted access

2.3: Estimating Creatinine Clearance

Edited by John E. Murphy

Restricted access

2.3 Toxicology—Level 3

Mary A. Babico and Hanna Phan

Restricted access

2.3 Toxicology—Level 3

Mary A. Babico and Hanna Phan

Restricted access

2.4: Renal Drug Dosing

Edited by John E. Murphy

Restricted access

2.5: Aminoglycoside Antibiotics

Edited by John E. Murphy

Restricted access

2.6: Carbamazepine

Edited by John E. Murphy

Restricted access

2.7: Digoxin

Edited by John E. Murphy

Restricted access

2.8: Unfractionated Heparin and Low Molecular Weight Heparins

Edited by John E. Murphy

Restricted access

2.9: Lithium

Edited by John E. Murphy

Restricted access

3.1 Patent Ductus Arteriosus—Level 1

Brady S. Moffett

Restricted access

3.1 Patent Ductus Arteriosus—Level 1

Brady S. Moffett

Restricted access

3.2 Hypertension—Level 2

Brady S. Moffett

Restricted access

3.2 Hypertension—Level 2

Brady S. Moffett

Restricted access

3.3 Congenital Heart Defects—Level 3

Brady S. Moffett

Restricted access

3.3 Congenital Heart Defects—Level 3

Brady S. Moffett

Restricted access

4.1 Asthma—Level 1

Manar O. Lashkar and Hanna Phan

Restricted access

4.1 Asthma—Level 1

Manar O. Lashkar and Hanna Phan